Key Metrics 
Check Before You Invest 
10 Yrs X-Ray 
Valuation 
Analyst Note 
Qtr. Results 
Financials 
News 
About
BDH Industries Ltd (MBIND)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524828 NSE: MBIND Pharmaceuticals & Drugs | Small Cap | BDH Industries Share Price
₹505.05 5.05 (1.01%)
As on 23-Sep'26 11:25
BDH Industries Ltd (MBIND)
Share Analysis – Quality, Valuation Zone, Price Trend & DeciZen Rating BSE: 524828 NSE: MBIND Pharmaceuticals & Drugs | Small Cap | BDH Industries Share Price
₹505.05 5.05 (1.01%)
As on 23-Sep'26 11:25
Key Metrics
Valuation Multiples
Market Cap
₹288 Cr.
Current Price
₹505.1
52-Week Low / High
₹340 / 610
TTM EPS
-
TTM Sales
-
Book Value per Share
-
P/E Ratio
Industry PE
54.8
Price to Book (P/B)
Price to Sales (P/S)
EV/EBITDA
Dividend Yield
0%
Profitability Efficiency
Return on Equity (ROE)
%
Return on Capital Employed (ROCE)
%
Return on Assets (ROA)
%
Operating Profit Margin
0%
Net Profit Margin
-%
Gross Profit Margin
0%
Growth Momentum
1-yr vs 3-yr growth
1-yr vs 3-yr growth
Sales Growth (1 Year)
Improving versus 3-year growth rate
44.26%
Operating Profit Growth (1 Year)
-
-
Net Profit Growth (1 Year)
-
-
Asset Quality
Promoter Holding
49.70%
Pledged shares (%) of Promoter's holding (%)
0.00%
Reserves
-
Equity
₹5.8 Cr.
Face Value
₹10
All Time Low / High
₹2.45 / 610.00
Check Before You Invest
Quality
Not GoodValuation
OvervaluedCheck Valuation charts
Price Trend
Weak
Is BDH Industries Ltd a good quality company?
BDH Industries Ltd is a weak quality company, based on a inconsistent multi-year financial track record.
This assessment is based on company’s performance on Revenue growth, ROCE, Equity and Assets, key margin ratios, cash conversion cycle, and debt to cash flow from operations and how it compares with its long term averages.
We have analysed the performance of the company on the following:
-
How has it performed on generating Profits?
By checking its Revenue growth, Gross, Operating and Net Margins compared to its last 5-year median.
-
How efficiently has it utilized Capital?
By checking its ROCE, ROA, ROE and its Cash Conversion Cycle.
-
How is it managing its Debt?
By checking its Debt to Equity and Cash Flow from Operations.
How does BDH Industries Ltd performance compare with that of its Peers?
Revenue growth of BDH Industries Ltd vs industry peers?
BDH Industries Ltd revenue CAGR is %, compared to the industry median CAGR of 0%, indicating stable growth and maintaining its market share.
Promoter shareholding and pledge status of BDH Industries Ltd?
Promoters hold 49.70% of the BDH Industries Ltd, with 0.00% of their stake pledged, indicating no pledge risk.
Stock return of BDH Industries Ltd over the last decade?
Over the last 9 year(s), the stock has delivered a CAGR of 21.2% based on the current price.
10 Year X-Ray :
Analysis of Financial Track Record (Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end)
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year endData adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.
What is a Financial Track Record? How to read this chart in order to understand the data present here?
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
BDH Industries Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good
Value Creation ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROCE % ⓘ | 14.9% | 14.7% | 16.9% | 19.1% | 18.7% | 19.6% | 20.8% | 21% | 18.2% | 20.9% | - |
| Value Creation Index ⓘ | 0.1 | 0.1 | 0.2 | 0.4 | 0.3 | 0.4 | 0.5 | 0.5 | 0.3 | 0.5 | - |
Growth Parameters ⓘ |
|||||||||||
| Sales ⓘ | 43.7 | 41 | 51.7 | 59.5 | 57.5 | 69.4 | 74.5 | 85.8 | 66.5 | 96 | 100 |
| Sales YoY Gr. | - | -6.1% | 26% | 15.1% | -3.4% | 20.8% | 7.3% | 15.3% | -22.5% | 44.3% | - |
| Adj EPS ⓘ | 5.8 | 6.5 | 8.4 | 10.3 | 11.1 | 12 | 14.3 | 17.1 | 16.1 | 18.8 | 20.3 |
| YoY Gr. | - | 12.8% | 28.3% | 23% | 7.1% | 8.6% | 18.8% | 20.3% | -6% | 16.6% | - |
| BVPS (₹) ⓘ | 48 | 51.6 | 56.9 | 63.7 | 72.2 | 82.1 | 92.7 | 105.7 | 117.1 | 131.5 | 136.2 |
| Adj Net Profit ⓘ | 3.3 | 3.8 | 4.8 | 5.9 | 6.4 | 6.9 | 8.2 | 9.9 | 9.3 | 10.8 | 12 |
| Cash Flow from Ops. ⓘ | 7.2 | -0.2 | -3.6 | 11.4 | 0.8 | 3 | 6.3 | -1.9 | 14.8 | -2.4 | - |
| Debt/CF from Ops. ⓘ | 1.2 | -51.5 | -3.6 | 0.8 | 10.9 | 0.8 | 0.8 | -4.7 | 0.1 | -0.8 | - |
CAGR ⓘ
| 9 Years | 5 Years | 3 Years | 1 Years | |||||
|---|---|---|---|---|---|---|---|---|
| Sales ⓘ | 9.1% | 10.8% | 8.8% | 44.3% | ||||
| Adj EPS ⓘ | 14% | 11.2% | 9.6% | 16.6% | ||||
| BVPSⓘ | 11.8% | 12.8% | 12.4% | 12.2% | ||||
| Share Price | 21.1% | 33.3% | 41.8% | 13.6% | ||||
Key Financial Parameters ⓘ
| Mar'17 | Mar'18 | Mar'19 | Mar'20 | Mar'21 | Mar'22 | Mar'23 | Mar'24 | Mar'25 | Mar'26 | TTM | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Return on Equity % ⓘ | 11.8 | 12.5 | 14.7 | 16.4 | 15.6 | 15.1 | 15.9 | 16.9 | 14.2 | 14.8 | 15.2 |
| Op. Profit Mgn % ⓘ | 11 | 13.1 | 13.6 | 15.1 | 14.8 | 13.1 | 14.7 | 14.5 | 17.5 | 14.5 | 15.3 |
| Net Profit Mgn % ⓘ | 7.6 | 9.2 | 9.3 | 10 | 11.1 | 10 | 11 | 11.5 | 13.9 | 11.3 | 11.8 |
| Debt to Equity ⓘ | 0.3 | 0.3 | 0.4 | 0.3 | 0.2 | 0.1 | 0.1 | 0.1 | 0 | 0 | - |
| Working Cap Days ⓘ | 111 | 132 | 155 | 146 | 156 | 154 | 160 | 175 | 229 | 164 | 144 |
| Cash Conv. Cycle ⓘ | -34 | -44 | -13 | -4 | -6 | 8 | 6 | 21 | 29 | 39 | 108 |
Valuation of BDH Industries - Consolidated
Analyst's Notes
No data found!
Management X-Ray
Shareholding Pattern
Promoter's Holding & Share Pledging
| Pledged * | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 8.99 | 0.00 |
* Pledged shares as % of Promoter's holding (%)
Financials
No data found!
No data found!
No data found!
No data found!
Top 5 Mutual Funds Holding
Last Visited Stocks
Announcements
BDH Industries Ltd FAQs
The current trading price of BDH Industries on 23-Sep-2026 11:25 is ₹505.1.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 22-Sep-2026 the market cap of BDH Industries stood at ₹287.9 Cr
The latest P/E ratio of BDH Industries as of 22-Sep-2026 is 24.58.
The latest P/B ratio of BDH Industries as of 22-Sep-2026 is 3.67.
The 52-week high of BDH Industries is ₹610.0 and the 52-week low is ₹340.1.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of BDH Industries is ₹99.71 ( Cr.) .
Past 10 year’s financial track record analysis by Moneyworks4me indicates that BDH Industries Ltd is a below average quality company.
The key valuation ratios of BDH Industries Ltd's currently when compared to its past seem to suggest it is in the Overvalued zone.
The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of BDH Industries Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.
About BDH Industries Ltd
BDH Industries was incorporated on December 5, 1990 and was converted into a public limited company on April 29, 1994.
BDH Industries is engaged in the manufacture and marketing of formulations and bulk drugs. It is today recognised as one of India's leading manufacturers of therapeutic formulations covering wide range of pharmaceuticals.
BDH exports a wide range of finished pharmaceutical formulations and bulk drugs to leading organizations in several countries, including Australia, Bolivia, Denmark, Dominican Republic, Germany, Ghana, Japan, Kenya, Madagascar, Malaysia, Mozambique, Netherlands, Niger, Nigeria, Papua New Guinea, Yemen, Singapore, Sri Lanka, Sudan, West Indies, Zambia, Zimbabwe, etc.
Products offered by the Company:
Some of its therapeutical categories are:
1. Anti-cancer 2. Antibiotics & Anti-microbials 3. Cardiovascular 4. Psychotropic 5. External Preparations 6. Sterile Opthalmics Preparations 7. Generics & Branded Generics 8. Injectables
It also manufactures sildenafil citrate tablets for male impotency
Achievements:
- The Government of the India has accorded 'Star Export House' status to the company
- The Government of India also accredited the company with WHO-GMP Certification since 1982.
- It has received Federation of Indian Export Organisations (FIEO) Export Award 'Niryat Shree'
- The company has received Chemexcil Top Export Award
- It has also received Chemexcil Trishul Award for Consistent Export Performance
- It has received the Government of Maharashtra's Export Award
- Ministry of Commerce's Award from the President of India was conferred on the company.
- 2010
• BDH Industries won ‘Good Corporate Citizen’ Award by Bombay Chamber of Commerce & Industry 2010
• BDH Industries won State Pharmaceutical Corporation (SPC) Sri Lanka Merit Award 2010
• WHO-GMP Certificatation since 1982, renewed WHO-GMP in 2010
You have 45 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
